Healthcare companies are facing unprecedented challenges as a result of the COVID-19 crisis. This includes heightened enforcement risks. A key area of risk is the federal False Claims Act (FCA), a powerful tool for the DOJ to seek substantial penalties including three times the amount of money a company received in federal funds. The COVID-19 crisis and unprecedented federal economic response also bring heightened scrutiny and enforcement risk by the SEC and state attorneys general. These risks extend not only to healthcare companies but also to their executives, directors and potentially even private equity owners.
In the first segment of Goodwin’s Healthcare webinar series, hear about recent enforcement developments and ways to mitigate risk from a panel of Goodwin lawyers with experience helping healthcare companies, their executives and medical professionals navigate enforcement investigations.
To register for this event, please visit the registration page here.